Cancers
Prognostic Factors in the Treatment of Advanced Endometrial Cancer Patients: 12-Year Experience of an ESGO Certified Center.
Dimitrios Zouzoulas, Iliana Sofianou, Efthalia Markopoulou, Tilemachos Karalis, Kimon Chatzistamatiou, Vasilis Theodoulidis, Maria Topalidou, Eleni Timotheadou, Grigoris Grimbizis, Dimitrios Tsolakidis
Published: 202610.3390/cancers18020343
Abstract
(1) Background: Advance-stage endometrial cancer is a rare disease that encompasses a heterogeneous group of patients. Primary surgery is the treatment of choice, while neoadjuvant chemotherapy (NACT) seems to be an alternative option for inoperable…
Preview only. Read the full abstract at the source